Birch pollen allergy

Dreborg, S., Foueard, T. (1983). Allergy to apple, carrot and potato in children with birch pollen allergy. Allergy, 38, 167-172. 

Moller C, Dreborg S, Lanner A, Bjorksten B Oral immunotherapy of children with rhinocon-junctivitis due to birch pollen allergy. Allergy 1986 41 271-279. 

Helin, T., Haahtela, S., and Haahtela, T. 2002. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy A placebo-controlled double-blind study. Allergy 57 243-246. 

Bohle B, Zwolfer B, Heratizadeh A, Jahn-Schmid B, Antonia YD, Alter M, Keller W, Zuidmeer L, van Ree R, Werfel T, Ebner C Cooking birch pollen-related food divergent consequences for IgE- and T cell-mediated reactivity in vitro and in vivo. J Allergy Chn Immunol 2006 118 242-249. 

Karamloo, F., et al.. (1999). Molecular cloning and characterization of a birch pollen minor allergen. Bet v 5, belonging to a family of isoflavone reductase-related proteins, J. Allergy Clin. Immunol., 104, 991-999. 

Calkohven, P. G., Aalbers, M., Koshte, V. L., Pos, O., Oei, H. D., Aalberse, R. C. (1987). Cross-reaetivity among birch pollen, vegetables and fruits as detected by IgE antibodies is due to at least three different crossreactive structures. Allergy, 42, 382-390. 

Wiedermann U, Jahn-Schmid B, Bohle B, Repa A, Renz H, Kraft D, Ebner C Suppression of antigen-specific T and B cell responses by intranasal or oral administration of recombinant Bet v 1, the major birch pollen allergen, in a murine model of type I allergy. J Allergy Clin Immunol 1999 103 1202-1210. 

Wiedermann U, Herz U, Baier K, Vrtala S, Neuhaus-Steinmetz U, Bohle B, Dekan G, Renz H, Ebner C, Valenta R, Kraft D Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice. Int Arch Allergy Immunol 2001 126 68-77. 

Winkler B, Baier B, Wagner S, Repa A, Scheiner O, Kraft D, Wiedermann U Mucosal tolerance as therapy of type I allergy Intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice. Clin Exp Allergy 2002 32 30-36. 

Hufhagl K, Winkler B, Focke M, Baier K, Valenta R, Kraft D, Wiedermann U Induction of mucosal tolerance by coapplication of recombinant Bet v 1, the major birch pollen allergen, recombinant Phi p 1 and Phi p 5, major grass pollen allergens, in polysensitized mice. Allergy 2002 57(suppl 73) 49. 

Taudorf E, Laursen CL, Lanner A, Bjorksten B, Dreborg S, Soborg M, Week B Oral immunotherapy in birch pollen hay fever. J Allergy Clin Immunol 1987 80 153-161. 

Wiedermann U, Kraft D Induction of mucosal tolerance to Bet v 1, the major birch pollen allergen, a review. Allergy Clin Immunol Int 2002 14 17-24. 

Khinchi MS, Poulsen LK, Carat F, Andre C, Mailing HJ Clinical efficacy of sublingual-swallow and subcutaneous immunotherapy in patients with allergic rhinoconjunctivitis due to birch pollen. A double-blind, double-dummy placebo-controlled study. Allergy 2000 54(suppl 63) 24. 

Voltolini S, Modena P, Minale P, Bignardi D, Troise C, Puccinelli P, Parmiani S Sublingual immunotherapy in tree pollen allergy. Double-blind, placebo-controlled study with a biologically standardised extract of three pollens (alder, birch and hazel) administered by a rush schedule. Allergol Immunopathol 2001 29 103-110. 

Senechal, H., Geny, S., Desvaux, F. X., Busson, M., Mayer, C., and Aron, Y. 1999. General and specific immune response in allergy to birch pollen and food (evidence of allergen positive association between atopy and the HLA class II allele HLA-DR7). J Allergy Clin Immunol 104 395M01. 

Fritsch, R., Bohle, B., Vollmann, U., Wiedermann, U., Jahn-Schmid, B., Krebitz, M. et al. 1998. Bet v 1, the major birch pollen allergen, and Mai d 1, the major apple allergen, cross-react at the level of allergen-specific T helper cells. J Allergy Clin Immunol 102(4 Pt 1 ) 679—686. 

C. A. Bmijnzeel-Koomen, L. S. Taams, E. F. Knol, E. van Hoffen, R. van Ree, and A. C. Knulst. 2004. Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges. Clin Exp Allergy 34 (5) 761—769. 

R. Kwiecien, B. Maderegger, and K. Hoffmann-Sommergruber. 2005. In vitro analysis of birch-pollen-associated food allergy by use of recombinant allergens in the basophil activation test. Int Arch Allergy Immunol 136 (3) 230-238. 

Kinaciyan, T., B. Jahn-Schmid, A. Radakovics, B. Zwolfer, C. Schreiber, J. N. Francis, C. Ebner, and B. Bohle. 2007. Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mai d 1. J Allergy Clin Immunol 119 (4) 937-943. 

Moverare, R., L. Elfman, E. Vesterinen, T. Metso, andT. Haahtela. 2002. Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System. Allergy 57 (5) 423-430. 

Niederberger, V., J. Reisinger, P. Valent, M. T. Krauth, G. Pauli, M. van Hage, O. Cromwell, F. Horak, and R. Valenta. 2007. Vaccination with genetically modified birch pollen allergens Immune and clinical effects on oral allergy syndrome. J Allergy Clin Immunol 119 (4) 1013—1016. 

Straumann, F. and B. Wuthrich. 2000. Food allergies associated with birch pollen Comparison of Allergodip and Pharmacia CAP for detection of specific IgE antibodies to birch pollen related foods. J Investig Allergol Clin Immunol 10 (3) 135-141. 

Ebner, C., Hirschwehr, R., Bauer, L. et al. 1995. Identification of allergens in fruits and vegetables IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin). J Allergy Clin Immunol 95 962-969. 

Flinterman, A.E., Hoekstra, M.O., Meijer, Y. et al. 2006. Clinical reactivity to hazelnut in children Association with sensitization to birch pollen or nuts J Allergy Clin Immunol 118 1186-1189. 

---